FIGURE 2:
FROM:
NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine
Ngozi Erondu, Carol Addy, Kaifeng Lu, Madhuja Mallick, Bret Musser, Ira Gantz, Joseph Proietto, Arne Astrup, Søren Toubro, Aila M. Rissannen, Serena Tonstad, William G. Haynes, Keith M. Gottesdiener, Keith D. Kaufman, John M. Amatruda and Steven B. Heymsfield
BACK TO ARTICLEFigure 2:.
Mean change from baseline in body weight (kg) over 24 weeks of treatment using LOCF (all-patients-treated population). †LS mean estimates (84% CI) based on ANCOVA model with terms for treatment, baseline body weight, center, and run-in weight change. p Values for comparisons are provided in Table 2 and in "Results."
